Skip to main content
SpringerLink
Log in

Heart Failure and Fatigue

  • Chapter
Heart Failure

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 172 Accesses

Abstract

Fatigue is one of the hallmark symptoms of heart failure and is present in a majority of patients. It leads to great limitation in physical activity and has a negative impact on quality of life. It occurs regardless of the etiology of the heart failure, is usually insidious in onset, and is an important part of the classification of symptom severity. Despite these facts, it is a symptom that can be difficult to quantify and difficult to distinguish from dyspnea, the other hallmark symptom of heart failure. It is a subjective complaint that has no single objective test to measure it. In addition, it can be multifactorial in origin. It is not adequately explained by a reduced cardiac output alone, and other factors such as peripheral muscle and vasculature abnormalities, neuroendocrine changes, depression, side effects of therapy, sleep disturbances, and other concomitant diseases all need to be considered as etiologic factors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lipkin DP, Poole-Wilson PA. Symptoms limiting exercise in chronic heart failure. Br Med J (Clin Res Ed) 1986;292:1030,1031.

    Google Scholar 

  2. Clark AL, Sparrow JL, Coats AJ. Muscle fatigue and dyspnoea in chronic heart failure: two sides of the same coin? Eur Heart J 1995;16:49–52.

    Article  PubMed  CAS  Google Scholar 

  3. Lipkin DP, Canepa-Anson R, Stephens MR, et al. Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. Br Heart J 1986;55:439–445.

    Article  PubMed  CAS  Google Scholar 

  4. Mancini DM, Schwartz M, Ferraro N, et al. Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol 1990;65:1121–1126.

    Article  PubMed  CAS  Google Scholar 

  5. Panciroli C, Galloni G, Oddone A, et al. Prognostic value of hyponatremia in patients with severe chronic heart failure. Angiology 1990 41:631–638.

    Article  PubMed  CAS  Google Scholar 

  6. Mancini DM, Walter G, Reichek N, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992;85:1364–1373.

    Article  PubMed  CAS  Google Scholar 

  7. Minotti JR, Pillay P, Oka R, et al. Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol 1993;75:373–381.

    PubMed  CAS  Google Scholar 

  8. Lipkin DP, Jones DA, Round JM, et al. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 1988;18:187–195.

    Article  PubMed  CAS  Google Scholar 

  9. Mancini DM, Coyle E, Loggan A, et al. Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 1989;80:1338–1346.

    Article  PubMed  CAS  Google Scholar 

  10. Drexler H, Riede U, Munzel T, et al. Alterations of skeletal muscle in chronic heart failure. Circulation 1992;85:1751–1759.

    Article  PubMed  CAS  Google Scholar 

  11. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990 81:518–527.

    Article  PubMed  CAS  Google Scholar 

  12. Massie BM, Conway M, Yonge R, et al. 31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol 1987;60:309–315.

    Article  PubMed  CAS  Google Scholar 

  13. Wilson JR, Fink L, Maris J, et al. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation 1985;71:57–62.

    Article  PubMed  CAS  Google Scholar 

  14. Wilson JR, Martin JL, Schwartz D, et al. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 1984;69:1079–1087.

    Article  PubMed  CAS  Google Scholar 

  15. Weber KT, Janicki JS. Lactate production during maximal and submaximal exercise in patients with chronic heart failure. J Am Coll Cardiol 1985;6:717–724.

    Article  PubMed  CAS  Google Scholar 

  16. Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 1988;77:552–559.

    Article  PubMed  CAS  Google Scholar 

  17. Lunde PK, Verburg E, Vollestad NK, et al. Skeletal muscle fatigue in normal subjects and heart failure patients. Is there a common mechanism? Acta Physiol Scand 1998;162:215–228.

    Article  PubMed  CAS  Google Scholar 

  18. Minotti JR, Johnson EC, Hudson TL, et al. Skeletal muscle response to exercise training in congestive heart failure. J Clin Invest 1990;86:751–758.

    Article  PubMed  CAS  Google Scholar 

  19. Meyer K, Schwaibold M, Westbrook S, et al. Effects of short-term exercise training and activity restriction on functional capacity in patients with severe chronic congestive heart failure. Am J Cardiol 1996;78:1017–1022.

    Article  PubMed  CAS  Google Scholar 

  20. Hambrecht R, Niebauer J, Fiehn E, et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol 1995;25:1239–1249.

    Article  PubMed  CAS  Google Scholar 

  21. Belardinelli R, Georgiou D, Scocco V, et al. Low intensity exercise training in patients with chronic heart failure. J Am Coll Cardiol 1995;26:975–982.

    Article  PubMed  CAS  Google Scholar 

  22. Mancini DM, Henson D, La Manca J, et al. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation 1992;86:909–918.

    Article  PubMed  CAS  Google Scholar 

  23. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993; 9:317–343.

    Article  PubMed  CAS  Google Scholar 

  24. Linke A, Schoene N, Gielen S, et al. Endothelial dysfunction in patients with chronic heart failure: systemic effects of lower-limb exercise training. J Am Coll Cardiol 2001;37:392–397.

    Article  PubMed  CAS  Google Scholar 

  25. Hambrecht R, Fiehn E, Weigl C, et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998;98:2709–2715.

    Article  PubMed  CAS  Google Scholar 

  26. Jeserich M, Pape L, Just H, et al. Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with chronic congestive heart failure. Am J Cardiol 1995:76:1079–1082.

    Article  PubMed  CAS  Google Scholar 

  27. Kapadia SR, Yakoob K, Nader S, et al. Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol 2000;36:208–212.

    Article  PubMed  CAS  Google Scholar 

  28. Habib FM, Springall DR, Davies GJ, et al. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 1996;347:1151–1155.

    Article  PubMed  CAS  Google Scholar 

  29. Satoh M, Nakamura M, Tamura G, et al. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol 1997;29:716–724.

    Article  PubMed  CAS  Google Scholar 

  30. Kubota T, Miyagishima M, Frye CS, et al. Overexpression of tumor necrosis factoralpha activates both anti- and pro-apoptotic pathways in the myocardium. J Mol Cell Cardiol 2001;33:1331–1344.

    Article  PubMed  CAS  Google Scholar 

  31. Agnoletti L, Curello S, Bachetti T, et al. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factoralpha. Circulation 1999;100:1983–1991.

    Article  PubMed  CAS  Google Scholar 

  32. Dalla Libera L, Sabbadini R, Renken C, et al. Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-alpha and sphingosine. J Mol Cell Cardiol 2001;33:1871–1878.

    Article  PubMed  CAS  Google Scholar 

  33. Anker SD, Ponikowski PP, Clark AL, et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999;20:683–693.

    Article  PubMed  CAS  Google Scholar 

  34. Anker SD, Clark AL, Texeira MM, et al. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol 1999;83:612–615, A10.

    Google Scholar 

  35. Anker SD, Swan JW, Volterrani M, et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J 1997;18:259–269.

    Article  PubMed  CAS  Google Scholar 

  36. Anker SD, Coats AJ. Cachexia in heart failure is bad for you. Eur Heart J 1998;19:191–193.

    PubMed  CAS  Google Scholar 

  37. Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236–241.

    Article  PubMed  CAS  Google Scholar 

  38. McMurray J, Abdullah I, Dargie HJ, et al. Increased concentrations of tumour necrosis factor in “cachectic” patients with severe chronic heart failure. Br Heart J 1991;66:356–358.

    Article  PubMed  CAS  Google Scholar 

  39. Anker SD, Clark AL, Kemp M, et al. Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol 1997;30:997–1001.

    Article  PubMed  CAS  Google Scholar 

  40. Tracey KJ, Morgello S, Koplin B, et al. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factorsecreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J Clin Invest 1990;86:2014–2024.

    Article  PubMed  CAS  Google Scholar 

  41. Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96:526–534.

    Article  PubMed  CAS  Google Scholar 

  42. Diagnostic and Statistical Manual for Mental Disorders: DSM-IV. American Psychiatric Association, Washington, DC: 1994, p. 358.

    Google Scholar 

  43. Koenig HG. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry 1998;20:29–43.

    Article  PubMed  CAS  Google Scholar 

  44. Murberg TA, Bru E, Srebak S, et al. Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: a two-years follow- up study. Int J Psychiatry Med 1999;29:311–326.

    Article  PubMed  CAS  Google Scholar 

  45. Freedland KE, Carney R, Rich MW, et al. Depression in elderly patients with congestive heart failure. J Geriatric Psychiatry 1991;24:59–71.

    Google Scholar 

  46. Dracup K, Walden JA, Stevenson LW, et al. Quality of life in patients with advanced heart failure. J Heart Lung Transplant 1992;11:273–279.

    PubMed  CAS  Google Scholar 

  47. Murberg TA, Bru E, Aarsland T, et al. Functional status and depression among men and women with congestive heart failure. Int J Psychiatry Med 1998;28:273–291.

    Article  PubMed  CAS  Google Scholar 

  48. Vaccarino V, Kasi SV, Abramson J, et al. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001;38:199–205.

    Article  PubMed  CAS  Google Scholar 

  49. Guiry E, Conroy RM, Hickey N, et al. Psychological response to an acute coronary event and its effect on subsequent rehabilitation and lifestyle change. Clin Cardiol 1987;10:256–260.

    Article  PubMed  CAS  Google Scholar 

  50. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998;97:2154–2159.

    Article  PubMed  CAS  Google Scholar 

  51. Javaheri S, Parker TJ, Wexler L, et al. Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 1995;122:487–492.

    PubMed  CAS  Google Scholar 

  52. Chan J, Sanderson J, Chan W, et al. Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 1997;111:1488–1493.

    Article  PubMed  CAS  Google Scholar 

  53. Burgess KR. Central sleep apnoea and heart failure (part II). Respirology 1998;3:1–11.

    Article  PubMed  CAS  Google Scholar 

  54. Hanly P, Zuberi-Khokhar N. Daytime sleepiness in patients with congestive heart failure and Cheyne- Stokes respiration. Chest 1995;107: 952–958.

    Article  PubMed  CAS  Google Scholar 

  55. Naughton MT, Benard DC, Liu PP, et al. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995;152:473–479.

    PubMed  CAS  Google Scholar 

  56. Bradley TD, Floras JS. Pathophysiologic and therapeutic implications of sleep apnea in congestive heart failure. J Card Fail 1996;2:223–240.

    Article  PubMed  CAS  Google Scholar 

  57. Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 1999;341:949–954.

    Article  PubMed  CAS  Google Scholar 

  58. Wilcox I, McNamara SG, Dodd MJ, et al. Ventilatory control in patients with sleep apnoea and left ventricular dysfunction: comparison of obstructive and central sleep apnoea. Eur Respir J 1998;11:7–13.

    Article  PubMed  CAS  Google Scholar 

  59. Javaheri S, Parker TJ, Wexler L, et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996;335:562–567.

    Article  PubMed  CAS  Google Scholar 

  60. DeBacker WA, Verbraecken J, Willemen M, et al. Central apnea index decreases after prolonged treatment with acetazolamide. Am J Respir Crit Care Med 1995;151:87–91.

    PubMed  CAS  Google Scholar 

  61. Franklin KA, Eriksson P, Sahlin C, et al. Reversal of central sleep apnea with oxygen. Chest 1997;111:163–169.

    Article  PubMed  CAS  Google Scholar 

  62. Javaheri S, Ahmed M, Parker TJ, et al. Effects of nasal 02 on sleep-related disordered breathing in ambulatory patients with stable heart failure. Sleep 1999;22:1101–1106.

    PubMed  CAS  Google Scholar 

  63. Andreas S, Clemens C, Sandholzer H, et al. Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996;27:1486–1490.

    Article  PubMed  CAS  Google Scholar 

  64. Granton JT, Naughton MT, Benard DC, et al. CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1996;153:277–282.

    PubMed  CAS  Google Scholar 

  65. Tkacova R, Rankin F, Fitzgerald FS, et al. Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure. J Am Coll Cardiol 1997;30:739–745.

    Article  PubMed  CAS  Google Scholar 

  66. Walsh JT, Andrews R, Starling R, et al. Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. Br Heart J 1995;73:237–241.

    Article  PubMed  CAS  Google Scholar 

  67. Skobel E, Kaminski R, Breuer C, et al. (Remission of nocturnal pathological respiratory patterns after orthotopic heart transplantation. A case report and overview of current status of therapy). Med Klin 2000;95:706–711.

    Article  CAS  Google Scholar 

  68. Physicians’ Desk Reference. 55th ed. Medical Economics Company, 2001.

    Google Scholar 

Download references

Authors
  1. Eric D. Popjes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Heart Failure/Transplant Program, University of Pennsylvania Health System, Philadelphia, PA, USA

    Mariell L. Jessup MD, FACC, FAHA

  2. University of Pennsylvania Health System, Philadelphia, PA, USA

    Evan Loh MD, FACC, FAHA

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Popjes, E.D. (2003). Heart Failure and Fatigue. In: Jessup, M.L., Loh, E. (eds) Heart Failure. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-347-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-347-7_4

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9759-5

  • Online ISBN: 978-1-59259-347-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation